CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-21 | Shukla Sanjay President and CEO | Purchase | +10,000 | $2.14 | $21K | 50,798 |
| 2022-07-01 | Shukla Sanjay President and CEO | Purchase | +15,000 | $2.88 | $43K | 40,798 |
| 2022-05-24 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +88,097 | 88,097 | ||
| 2022-05-24 | Broadfoot Jill Marie Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +75,347 | 75,347 | ||
| 2022-05-24 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (right to buy) | +516,280 | 516,280 | ||
| 2022-04-26 | Zaknoen Sara Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2022-04-26 | SCHIMMEL PAUL Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2022-04-26 | Lucas Svetlana Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2022-04-26 | Gross Jane A Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2022-04-26 | COUGHLIN TIMOTHY Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2022-04-26 | CLARKE JOHN K Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2022-02-03 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +21,500 | 21,500 | ||
| 2022-02-03 | DENYES NANCY General Counsel | Grant or award · Restricted Stock Units | +10,750 | 10,750 | ||
| 2022-02-03 | Broadfoot Jill Marie Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-02-03 | Broadfoot Jill Marie Chief Financial Officer | Grant or award · Restricted Stock Units | +15,000 | 15,000 | ||
| 2022-02-03 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (right to buy) | +83,000 | 83,000 | ||
| 2022-02-03 | Shukla Sanjay President and CEO | Grant or award · Restricted Stock Units | +41,500 | 41,500 | ||
| 2022-01-13 | Broadfoot Jill Marie Chief Financial Officer | Purchase | +1,923 | $6.75 | $13K | 12,112 |
| 2022-01-07 | Shukla Sanjay President and CEO | Purchase | +5,000 | $6.76 | $34K | 25,798 |
| 2021-11-15 | Shukla Sanjay President and CEO | Purchase | +2,500 | $8.58 | $21K | 20,798 |
Page 6 of 15 · 284 trades